Silencing PLOD2 Attenuates Cancer Stem Cell-Like Characteristics and Cisplatin-Resistant through Integrin β1 in Laryngeal Cancer

The effects of PLOD2 expression on ordinary and Cisplatin-resistance cells were investigated in TU686 and TU138 cells and Xenograft model.